Health · 3 views
Injectable Nanobody Wins FDA Approval for Myasthenia Gravis
(MedPage Today) -- The FDA on Friday approved injectable gefurulimab (Klygefa), a dual-binding nanobody that blocks complement component 5 (C5) activation, to treat generalized myasthenia gravis in adults who are anti-acetylcholine…
Summary
(MedPage Today) -- The FDA on Friday approved injectable gefurulimab (Klygefa), a dual-binding nanobody that blocks complement component 5 (C5) activation, to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- AHA: Discontinuing statins noninferior to continuation in older adults without known cardiovascular diseaseContinue reading
- More Measles Deaths Reported as U.S. Cases Top 5,400Continue reading
- What Was FDA's GLP-1 Warning About?Continue reading
- Shorter Cycle Maintains Efficacy of Colorectal Cancer RegimenContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow